Apimeds Pharmaceuticals US, Inc
$3.87
-0.08 (-2.03%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -21.3%
- 3 Months
- -72.6%
- YTD
- -76.4%
- 1 Year
- -79.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 146.9%
- Largest decline max drawdown, since Aug 2025
- -90.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.35
Own APUS?
See how APUS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.